Portola Pharmaceuticals to Participate in Two Upcoming Investor Conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
Portola Pharmaceuticals (PTLA) PT Lowered to $30 at Oppenheimer
November 8, 2018 8:29 AM ESTOppenheimer analyst Jay Olson lowered the price target on Portola Pharmaceuticals (NASDAQ: PTLA) to $30.00 (from $60.00) while maintaining a Outperform rating.
Olson commented, "PTLA introduced its new CEO and provided a business update in the context of 3Q results. Andexxa revenue at... More
Portola Pharmaceuticals (PTLA) PT Lowered to $30 at Credit Suisse
November 8, 2018 8:10 AM ESTCredit Suisse analyst Vamil Divan lowered the price target on Portola Pharmaceuticals (NASDAQ: PTLA) to $30.00 (from $34.00) while maintaining a Neutral rating.
... More